Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.41 | 1.4 |
NAV | ₹18.17 | ₹1901.79 |
Fund Started | 19 Feb 2019 | 08 Dec 1994 |
Fund Size | ₹379.57 Cr | ₹69639.05 Cr |
Exit Load | - | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.77% | 15.91% |
3 Year | 14.25% | 24.21% |
5 Year | 15.86% | 31.64% |
1 Year
3 Year
5 Year
Equity | 98.22% | 87.39% |
Cash | 1.50% | 11.01% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 4.66% |
Larsen & Toubro Ltd. | 2.76% |
HDFC Bank Ltd. | 2.25% |
Hindustan Petroleum Corporation Ltd. | 2.22% |
LTIMindtree Ltd. | 2.18% |
Tech Mahindra Ltd. | 2.16% |
Godrej Consumer Products Ltd. | 2.14% |
State Bank of India | 2.07% |
Jindal Steel & Power Ltd. | 2.04% |
Sun Pharmaceutical Industries Ltd. | 2.01% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.58% |
HDFC Bank Ltd. | 9.45% |
Axis Bank Ltd. | 8.86% |
Kotak Mahindra Bank Ltd. | 5.14% |
SBI Life Insurance Company Ltd. | 4.33% |
Maruti Suzuki India Ltd. | 4.14% |
Cipla Ltd. | 3.98% |
Bharti Airtel Ltd. | 3.19% |
HCL Technologies Ltd. | 2.74% |
Piramal Pharma Ltd. | 2.62% |
Name | Jonas Bhutta | Dhruv Muchhal |
Start Date | 22 Sep 2022 | 14 Sep 2023 |
Name
Start Date
Description | The Scheme seeks to invest primarily in a well-diversified portfolio of equity and equity related securities. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 19 Feb 2019 | 08 Dec 1994 |
Description
Launch Date